Kasha Global, an e-commerce platform operating the healthcare space, has announced an equity investment from Sanofi Global Health Unit’s Impact Investment Fund. Though the amount is not disclosed, the investment will support Kasha’s expansion into more countries across Africa, increase capabilities in Kasha’s technology platform and further grow Kasha’s ability to drive equitable access of health products across the continent.
In 2023, the Rwandan startup Kasha raised $21 million in a Series B funding round led by Knife Capital.
According to Joanna Bichsel, Kasha’s Founder and CEO; “It’s an exciting milestone for Kasha to partner so closely with Sanofi who is an important strategic partner for us. Over the years and across our countries of operations in Africa, Kasha has seen the fast growing demand for Non-Communicable Diseases (NCDs) like diabetes and hypertension. With this investment, we will scale up the awareness of NCDs and other health issues and make it easier and more affordable for people to get the medications they need, especially lower income and rural customers. Leveraging Kasha’s technology platform to drive access in a customer-driven and data-driven way, together Kasha and Sanofi can change the game in enabling full access to quality pharmaceuticals in Africa.”
Jon Fairest, Sanofi Head of the Global Health Unit, says: “We are excited to play a role in Kasha’s scale-up journey as an investor and partner through the Global Health Unit’s Impact Investment Fund. Kasha has built a unique physical and tech infrastructure for the last mile, enabling greater access to basic health products even in the most remote areas leveraging adjusted supply chain and a broad network of agents. We recognize the importance of investing in local entrepreneurial businesses that strengthen and support sustainable healthcare delivery models and improve outcomes. Sanofi’s Global Health Unit is dedicated to improving access to sustainable healthcare for vulnerable populations with the highest unmet medical needs.”
